Drug Shortage Report for NXSTAGE PUREFLOW SOLUTION RFP-209-CAN
Report ID | 76025 |
Drug Identification Number | 02443295 |
Brand name | NXSTAGE PUREFLOW SOLUTION RFP-209-CAN |
Common or Proper name | Hemodialysis Solution |
Company Name | NXSTAGE MEDICAL INC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM LACTATE DEXTROSE MAGNESIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE |
Strength(s) | 8.408G 1.1G 0.102G 0.221G 0.15G 5.552G |
Dosage form(s) | SOLUTION |
Route of administration | DIALYSIS |
Packaging size | 5 L |
ATC code | B05Z |
ATC description | HEMODIALYTICS AND HEMOFILTRATES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-02-11 |
Estimated end date | Unknown |
Actual end date | 2019-03-11 |
Shortage status | Resolved |
Updated date | 2019-03-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 350 MERRIMACK STREET LAWRENCE, MASSACHUSETTS UNITED STATES 01843 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-02-15 | English | Compare |
v2 | 2019-02-15 | English | Compare |
v3 | 2019-02-15 | French | Compare |
v4 | 2019-02-15 | English | Compare |
v5 | 2019-02-15 | French | Compare |
v6 | 2019-03-11 | English | Compare |
v7 | 2019-03-11 | English | Compare |
v8 | 2019-03-11 | English | Compare |
v9 | 2019-03-11 | French | Compare |
v10 | 2019-03-12 | English | Compare |
Showing 1 to 10 of 10